Vivera Engages Star Legal Team to Lead $500 Million Lawsuit Against USA Today
“Vivera Pharmaceuticals, Inc. today announced the appointment of leading corporate law firm, Byrd Campbell, P.A., to represent the Company in its defamation lawsuit against USA Today and its parent companies, Gannett Co., Inc. and Gannett Satellite Information Network, LLC (“Gannett”),” reports Vivera Pharmaceuticals in PR Newswire.
“The Settlement Class could have achieved at the time, the biopharmaceutical company’s investors said in a memo filed in support of their final settlement approval bid in the U.S. District Court for the District of Maryland. The settlement class covers everyone who acquired IGC’s publicly traded common stock from Sept. 26, 2018.”
